Digital Cultivating data-driven decisions: How to use content experi... Data-driven decisions matter, and it is hardly surprising when looking at statistics.
Digital Create, approve, deploy: supercharge comms with modular cont... Each year, pharma and life sciences invest large amounts of time and money in creating content designed to attract HCPs and call them to action.
News In shock move, EU panel rejects Alzheimer's drug Leqembi The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh
Sales & Marketing Sponsored How doctors are interacting with content in 10 data trends It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.